NCT06792604View on ClinicalTrials.gov

Host Genome Methylation: a Screening Tool in Anal Cancer Detection

NARecruitingINTERVENTIONAL
Enrollment

770

Participants

Timeline

Start Date

November 22, 2024

Primary Completion Date

November 22, 2028

Study Completion Date

November 22, 2028

Conditions
Anal Cancer
Interventions
DEVICE

Anal self-sampling (smear)

Anal self-sampling (smear) at M12, M24 and M36 (each year) for HPV16+ patients at M0 and anal self-sampling (smear) at M36 for HPV16- at M0

BEHAVIORAL

HPV questionnaire

HPV questionnaire at each visit M0, M12, M24 and M36 for HPV16-positive patients at M0 and HPV questionnaire at each visit M0, 4 and M36 for HPV16-negative patients

Trial Locations (9)

75018

ACTIVE_NOT_RECRUITING

Cardiovascular Surgery and Transplantation Department Bichat-Claude Bernard Hospital, Paris

NOT_YET_RECRUITING

Dermatology Department, Paris

RECRUITING

Gynecology and Obstetrics Department Bichat-Claude Bernard Hospital, Paris

ACTIVE_NOT_RECRUITING

Hepato-Gastroenterology, Digestive Oncology, and Proctology Department Bichat-Claude Bernard Hospital, Paris

RECRUITING

Infectious and Tropical Diseases Department Bichat-Claude Bernard Hospital, Paris

ACTIVE_NOT_RECRUITING

Nephrology Department Bichat-Claude Bernard Hospital, Paris

ACTIVE_NOT_RECRUITING

Pathological Anatomy and Cytology Department Bichat-Claude Hospital, Paris

ACTIVE_NOT_RECRUITING

Pulmonology B and Lung Transplantation Department Bichat-Claude Bernard Hospital, Paris

ACTIVE_NOT_RECRUITING

Virology Department Bichat-Claude Bernard Hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER